Truvestments Capital’s 2seventy bio TSVT Stock Holding History

Truvestments Capital’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-41	Closed	-$203	–	1094
2025 Q1	$203	Hold	41	–	–	﹤0.01%	992
2024 Q4	$121	Hold	41	–	–	﹤0.01%	985
2024 Q3	$194	Buy	+41	New	+$185	﹤0.01%	902
2024 Q2	–	Sell	-41	Closed	-$219	–	653
2024 Q1	$219	Hold	41	–	–	﹤0.01%	698
2023 Q4	$175	Hold	41	–	–	﹤0.01%	770
2023 Q3	$161	Hold	41	–	–	﹤0.01%	669
2023 Q2	$415	Hold	41	–	–	﹤0.01%	663
2023 Q1	$418	Hold	41	–	–	﹤0.01%	638
2022 Q4	$384	Sell	41 -2	-5%	-$28	﹤0.01%	879
2022 Q3	$1K	Hold	43	–	–	﹤0.01%	607
2022 Q2	$1K	Buy	+43	New	+$586	﹤0.01%	627

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Truvestments Capital's TSVT Position: Q2 2025 in Review

Truvestments Capital sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 41 shares — an estimated $203 sold.

Truvestments Capital first reported a position in TSVT in Q2 2022 and held it in 11 quarters. The position peaked at $1K in Q3 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Truvestments Capital reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Truvestments Capital sold 41 2seventy bio shares in Q2 2025, an estimated $203.
Truvestments Capital first reported a position in 2seventy bio in Q2 2022 and held it in 11 quarters.
Truvestments Capital's 2seventy bio position peaked at $1K in Q3 2022.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Truvestments Capital's 13F filing for Q2 2025, filed 13 Aug 2025.